Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7150/thno.11862 http://scihub22266oqcxt.onion/10.7150/thno.11862 C4402493!4402493!25897334     free     free     free       Theranostics 2015 ; 5 (7): 686-97 Nephropedia Template TP {{tp|p=25897334|t=2015. Lymphatic Imaging: Focus on Imaging Probes |pdf=|usr=}}{{25897334}} gab.com Text Lymphatic Imaging: Focus on Imaging Probes JO: Theranostics http://www.kidney.de/pget.php?&tw=1&pmid=25897334 #FOAvip In view of the importance of sentinel lymph nodes (SLNs) in tumor staging and patient management, sensitive and accurate imaging of SLNs has been intensively explored. Along with the advance of the imaging technology, various contrast agents have been developed for lymphatic imaging. In this review, the lymph node imaging agents were summarized into three groups: tumor targeting agents, lymphatic targeting agents and lymphatic mapping agents. Tumor targeting agents are used to detect metastatic tumor tissue within LNs, lymphatic targeting agents aim to visualize lymphatic vessels and lymphangionesis, while lymphatic mapping agents are mainly for SLN detection during surgery after local administration. Coupled with various signal emitters, these imaging agents work with single or multiple imaging modalities to provide a valuable way to evaluate the location and metastatic status of SLNs. Twit Text FOAVip Lymphatic Imaging: Focus on Imaging Probes ????Theranostics http://www.kidney.de/pget.php?&tw=1&pmid=25897334 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25897334 #FOAvip English Wikipedia <ref>{{Cite pmid|25897334}}</ref> Lymphatic Imaging: Focus on Imaging Probes #MMPMID25897334 Niu G; Chen X Theranostics 2015[]; 5 (7): 686-97 PMID25897334show ga In view of the importance of sentinel lymph nodes (SLNs) in tumor staging and patient management, sensitive and accurate imaging of SLNs has been intensively explored. Along with the advance of the imaging technology, various contrast agents have been developed for lymphatic imaging. In this review, the lymph node imaging agents were summarized into three groups: tumor targeting agents, lymphatic targeting agents and lymphatic mapping agents. Tumor targeting agents are used to detect metastatic tumor tissue within LNs, lymphatic targeting agents aim to visualize lymphatic vessels and lymphangionesis, while lymphatic mapping agents are mainly for SLN detection during surgery after local administration. Coupled with various signal emitters, these imaging agents work with single or multiple imaging modalities to provide a valuable way to evaluate the location and metastatic status of SLNs. äLymphatic Imaging: Focus on Imaging Probes (epmc).pdf DeepDyve Pubget Overpricing